Literature DB >> 17684724

Neuronal nitric oxide synthase deficiency decreases survival in bacterial peritonitis and sepsis.

Xizhong Cui1, Virginia Besch, Alfia Khaibullina, Adrienne Hergen, Martha Quezado, Peter Eichacker, Zenaide M N Quezado.   

Abstract

OBJECTIVE: To investigate the role of neuronal nitric oxide synthase (NOS1) in murine polymicrobial peritonitis and sepsis.
DESIGN: Randomized experimental trial.
SETTING: Animal research facility.
SUBJECTS: B6129S NOS1+/+ and B6;129S4 NOS-/- mice.
INTERVENTIONS: NOS1+/+ and NOS1-/- animals underwent cecal ligation and puncture (CLP) or sham surgery and received the NOS1 inhibitor 7-nitroindazole (7-NI) or vehicle.
MEASUREMENTS AND MAIN RESULTS: After CLP, genetic deficiency and pharmacologic inhibition of NOS1 significantly increased risk of mortality [8.69 (3.27, 23.1), p<0.0001 and 1.71 (1.00, 2.92) p=0.05, hazard ratio of death (95% confidence interval) for NOS1-/- and 7-NI-treated NOS1+/+ respectively] compared with NOS1+/+ animals. In 7-NI-treated NOS1+/+ animals, there were increases (6 h) and then decreases (24 h), whereas in NOS-/- animals persistent increases in blood bacteria counts (p=0.04 for differing effects of 7-NI and NOS1-/-) were seen compared with NOS1(+/+) animals. After CLP, NOS1(-/-) had upregulation of inducible NOS and proinflammatory cytokines and greater increases in serum tumor necrosis factor-alpha and interleukin-6 levels compared with NOS1+/+ mice (all p<0.05). Following CLP, there were similar significant decreases in circulating leukocytes and lung lavage cells (p<or=0.0008) and significant increases in peritoneal lavage cells (p=0.0045) in all groups. Over 6 h and 24 h following CLP, compared with NOS1+/+, NOS-/- mice had significantly higher peritoneal cell concentrations {respectively 0.40+/-0.09 vs 0.79+/-0.15 [log(x10(4)cells/ml)] averaged over both times p=0.038}.
CONCLUSIONS: Deficiency and inhibition of NOS1 increases mortality, possibly by increasing proinflammatory cytokine response and impairing bacterial clearance after CLP. These data suggest that NOS1 is important for survival, bacterial clearance, and regulation of cytokine response during infection and sepsis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17684724      PMCID: PMC3380429          DOI: 10.1007/s00134-007-0814-9

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  32 in total

1.  Human recombinant interleukin-1 alpha protection against the lethality of endotoxin and experimental sepsis in mice.

Authors:  H R Alexander; G M Doherty; D L Fraker; M I Block; J E Swedenborg; J A Norton
Journal:  J Surg Res       Date:  1991-05       Impact factor: 2.192

Review 2.  Signal transduction through NF-kappa B.

Authors:  M J May; S Ghosh
Journal:  Immunol Today       Date:  1998-02

3.  rG-CSF reduces endotoxemia and improves survival during E. coli pneumonia.

Authors:  B D Freeman; Z Quezado; F Zeni; C Natanson; R L Danner; S Banks; M Quezado; Y Fitz; J Bacher; P Q Eichacker
Journal:  J Appl Physiol (1985)       Date:  1997-11

4.  Human and rat neutrophils constitutively express neural nitric oxide synthase mRNA.

Authors:  S S Greenberg; J Ouyang; X Zhao; T D Giles
Journal:  Nitric Oxide       Date:  1998       Impact factor: 4.427

5.  Neuronal (type I) nitric oxide synthase regulates nuclear factor kappaB activity and immunologic (type II) nitric oxide synthase expression.

Authors:  H Togashi; M Sasaki; E Frohman; E Taira; R R Ratan; T M Dawson; V L Dawson
Journal:  Proc Natl Acad Sci U S A       Date:  1997-03-18       Impact factor: 11.205

Review 6.  Cardiovascular and renal control in NOS-deficient mouse models.

Authors:  Pablo A Ortiz; Jeffrey L Garvin
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2003-03       Impact factor: 3.619

7.  Targeted disruption of the neuronal nitric oxide synthase gene.

Authors:  P L Huang; T M Dawson; D S Bredt; S H Snyder; M C Fishman
Journal:  Cell       Date:  1993-12-31       Impact factor: 41.582

8.  Inhibition of neuronal nitric oxide synthase by 7-nitroindazole attenuates acute lung injury in an ovine model.

Authors:  Perenlei Enkhbaatar; Kazunori Murakami; Katsumi Shimoda; Akio Mizutani; Roy McGuire; Frank Schmalstieg; Robert Cox; Hal Hawkins; Jeffery Jodoin; Steve Lee; Lillian Traber; David Herndon; Daniel Traber
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2003-05-22       Impact factor: 3.619

9.  Lack of correlation between the reduction of sevoflurane MAC and the cerebellar cyclic GMP concentrations in mice treated with 7-nitroindazole.

Authors:  F Ichinose; W D Mi; M Miyazaki; T Onouchi; T Goto; S Morita
Journal:  Anesthesiology       Date:  1998-07       Impact factor: 7.892

10.  Effects of cerebral ischemia in mice deficient in neuronal nitric oxide synthase.

Authors:  Z Huang; P L Huang; N Panahian; T Dalkara; M C Fishman; M A Moskowitz
Journal:  Science       Date:  1994-09-23       Impact factor: 47.728

View more
  12 in total

1.  The three isoforms of nitric oxide synthase distinctively affect mouse nocifensive behavior.

Authors:  Julia Finkel; Virginia Guptill; Alfia Khaibullina; Nicholas Spornick; Olavo Vasconcelos; David J Liewehr; Seth M Steinberg; Zenaide M N Quezado
Journal:  Nitric Oxide       Date:  2011-12-17       Impact factor: 4.427

2.  Disruption of the transient receptor potential vanilloid 1 can affect survival, bacterial clearance, and cytokine gene expression during murine sepsis.

Authors:  Virginia Guptill; Xizhong Cui; Alfia Khaibullina; Jason M Keller; Nicholas Spornick; Andrew Mannes; Michael Iadarola; Zenaide M N Quezado
Journal:  Anesthesiology       Date:  2011-05       Impact factor: 7.892

3.  The expanding roles of neuronal nitric oxide synthase (NOS1).

Authors:  Kundan Solanki; Sajjan Rajpoot; Evgeny E Bezsonov; Alexander N Orekhov; Rohit Saluja; Anita Wary; Cassondra Axen; Kishore Wary; Mirza S Baig
Journal:  PeerJ       Date:  2022-07-07       Impact factor: 3.061

Review 4.  Bench-to-bedside review: nitric oxide in critical illness--update 2008.

Authors:  Steven M Hollenberg; Ismail Cinel
Journal:  Crit Care       Date:  2009-07-16       Impact factor: 9.097

5.  SERCA Cys674 sulphonylation and inhibition of L-type Ca2+ influx contribute to cardiac dysfunction in endotoxemic mice, independent of cGMP synthesis.

Authors:  Ion A Hobai; Emmanuel S Buys; Justin C Morse; Jessica Edgecomb; Eric H Weiss; Antonis A Armoundas; Xiuyun Hou; Alok R Khandelwal; Deborah A Siwik; Peter Brouckaert; Richard A Cohen; Wilson S Colucci
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-08-09       Impact factor: 4.733

Review 6.  The potential of nitric oxide releasing therapies as antimicrobial agents.

Authors:  David O Schairer; Jason S Chouake; Joshua D Nosanchuk; Adam J Friedman
Journal:  Virulence       Date:  2012-05-01       Impact factor: 5.882

7.  Local anaesthetics upregulate nitric oxide generation in cord blood and adult human neutrophils.

Authors:  Karolina I Kulinska; Maria Billert; Krzysztof Sawinski; Katarzyna Czerniak; Michał Gaca; Krzysztof Kusza; Krzysztof W Nowak; Maria Siemionow; Hanna Billert
Journal:  Sci Rep       Date:  2019-01-24       Impact factor: 4.379

8.  The heart is an early target of anthrax lethal toxin in mice: a protective role for neuronal nitric oxide synthase (nNOS).

Authors:  Mahtab Moayeri; Devorah Crown; David W Dorward; Don Gardner; Jerrold M Ward; Yan Li; Xizhong Cui; Peter Eichacker; Stephen H Leppla
Journal:  PLoS Pathog       Date:  2009-05-29       Impact factor: 6.823

9.  Differential protection against oxidative stress and nitric oxide overproduction in cardiovascular and pulmonary systems by propofol during endotoxemia.

Authors:  Yen-Chin Liu; Alice Y W Chang; Yu-Chuan Tsai; Julie Y H Chan
Journal:  J Biomed Sci       Date:  2009-01-15       Impact factor: 8.410

Review 10.  Year in review in Intensive Care Medicine, 2007. I. Experimental studies. Clinical studies: brain injury and neurology, renal failure and endocrinology.

Authors:  Massimo Antonelli; Elie Azoulay; Marc Bonten; Jean Chastre; Giuseppe Citerio; Giorgio Conti; Daniel De Backer; François Lemaire; Herwig Gerlach; Johan Groeneveld; Goran Hedenstierna; Duncan Macrae; Jordi Mancebo; Salvatore M Maggiore; Alexandre Mebazaa; Philipp Metnitz; Jerôme Pugin; Jan Wernerman; Haibo Zhang
Journal:  Intensive Care Med       Date:  2008-01-04       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.